Dimensional Fund Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.8M Sell
2,052,356
-105,175
-5% -$1.42M 0.01% 1786
2025
Q4
$24.2M Sell
2,157,531
-195,103
-8% -$2.23M 0.01% 1885
2025
Q3
$27.2M Sell
2,352,634
-225,430
-9% -$2.64M 0.01% 1843
2025
Q2
$31.6M Sell
2,578,064
-17,289
-0.7% -$217K 0.01% 1758
2025
Q1
$37.2M Buy
2,595,353
+17,036
+0.7% +$266K 0.01% 1622
2024
Q4
$41M Sell
2,578,317
-11,668
-0.5% -$231K 0.01% 1624
2024
Q3
$62.2M Buy
2,589,985
+12,350
+0.5% +$282K 0.02% 1372
2024
Q2
$51.3M Sell
2,577,635
-102,681
-4% -$2M 0.01% 1451
2024
Q1
$53.4M Sell
2,680,316
-173,919
-6% -$3.36M 0.01% 1410
2023
Q4
$64M Sell
2,854,235
-55,750
-2% -$1.15M 0.02% 1267
2023
Q3
$58.8M Sell
2,909,985
-208,167
-7% -$4.72M 0.02% 1232
2023
Q2
$79.7M Sell
3,118,152
-55,642
-2% -$1.47M 0.03% 1004
2023
Q1
$94.4M Buy
3,173,794
+281,958
+10% +$8.19M 0.03% 858
2022
Q4
$78.3K Buy
2,891,836
+64,029
+2% +$1.57M 0.02% 958
2022
Q3
$61.6M Buy
2,827,807
+188,035
+7% +$4.91M 0.02% 1052
2022
Q2
$72.2M Buy
2,639,772
+273,823
+12% +$7.87M 0.03% 985
2022
Q1
$79.3M Buy
2,365,949
+271,105
+13% +$8.73M 0.02% 1023
2021
Q4
$72.6M Sell
2,094,844
-76,655
-4% -$2.48M 0.02% 1135
2021
Q3
$67.8M Sell
2,171,499
-209,594
-9% -$7.11M 0.02% 1160
2021
Q2
$86.6M Buy
2,381,093
+111,696
+5% +$4.62M 0.03% 971
2021
Q1
$99.3M Buy
2,269,397
+57,263
+3% +$2.69M 0.03% 838
2020
Q4
$101M Buy
2,212,134
+5,442
+0.2% +$227K 0.04% 724
2020
Q3
$73.3M Buy
2,206,692
+23,833
+1% +$762K 0.03% 839
2020
Q2
$64.2M Sell
2,182,859
-175,307
-7% -$5.08M 0.03% 958
2020
Q1
$63.5M Buy
2,358,166
+68,367
+3% +$2.04M 0.03% 782
2019
Q4
$77.2M Buy
2,289,799
+7,992
+0.4% +$289K 0.03% 980
2019
Q3
$85.5M Buy
2,281,807
+67,451
+3% +$2.57M 0.03% 818
2019
Q2
$96.6M Sell
2,214,356
-175,831
-7% -$7.52M 0.04% 713
2019
Q1
$102M Sell
2,390,187
-442,268
-16% -$19.8M 0.04% 648
2018
Q4
$127M Sell
2,832,455
-286,879
-9% -$15M 0.06% 364
2018
Q3
$214M Sell
3,119,334
-127,366
-4% -$8.2M 0.08% 215
2018
Q2
$186M Sell
3,246,700
-174,597
-5% -$9.23M 0.07% 246
2018
Q1
$158M Buy
3,421,297
+40,934
+1% +$1.94M 0.07% 324
2017
Q4
$156M Buy
3,380,363
+87,880
+3% +$4.04M 0.06% 332
2017
Q3
$148M Buy
3,292,483
+159,434
+5% +$6.8M 0.06% 341
2017
Q2
$123M Buy
3,133,049
+507,893
+19% +$19.2M 0.06% 409
2017
Q1
$100M Buy
2,625,156
+415,105
+19% +$16.2M 0.05% 527
2016
Q4
$81.7M Buy
2,210,051
+330,186
+18% +$11.8M 0.04% 639
2016
Q3
$65.2M Buy
1,879,865
+339,988
+22% +$11.9M 0.04% 759
2016
Q2
$50.1M Buy
1,539,877
+103,829
+7% +$3.18M 0.03% 971
2016
Q1
$41.3M Buy
1,436,048
+237,032
+20% +$6.32M 0.02% 1136
2015
Q4
$40.1M Sell
1,199,016
-85,152
-7% -$2.65M 0.03% 1092
2015
Q3
$36.5M Buy
1,284,168
+183,206
+17% +$6.39M 0.02% 1133
2015
Q2
$44.6M Buy
1,100,962
+691,257
+169% +$31M 0.03% 987
2015
Q1
$20.2M Buy
409,705
+354,527
+643% +$16.4M 0.01% 1782
2014
Q4
$2.51M Buy
+55,178
New +$2.17M ﹤0.01% 2779

Other funds holding AVNS